ATA2979A - Verfahren zur herstellung von neuen 4''-deoxy- -4''-acylamidoderivaten von oleandomycin, erythromycin und erythromycincarbonat - Google Patents

Verfahren zur herstellung von neuen 4''-deoxy- -4''-acylamidoderivaten von oleandomycin, erythromycin und erythromycincarbonat

Info

Publication number
ATA2979A
ATA2979A AT2979A AT2979A ATA2979A AT A2979 A ATA2979 A AT A2979A AT 2979 A AT2979 A AT 2979A AT 2979 A AT2979 A AT 2979A AT A2979 A ATA2979 A AT A2979A
Authority
AT
Austria
Prior art keywords
erythromycincarbonate
oleandomycin
erythromycin
deoxy
producing new
Prior art date
Application number
AT2979A
Other languages
English (en)
Other versions
AT364457B (de
Inventor
Frank Christian Sciavolino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to AT595880A priority Critical patent/AT371481B/de
Publication of ATA2979A publication Critical patent/ATA2979A/de
Application granted granted Critical
Publication of AT364457B publication Critical patent/AT364457B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0002979A 1978-01-03 1979-01-02 Verfahren zur herstellung von neuen 4''-deoxy-4''-acylamidoderivaten von oleandomycin, erythromycin und erythromycincarbonat AT364457B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT595880A AT371481B (de) 1978-01-03 1980-12-05 Verfahren zur herstellung von neuen 4''-deoxy-4''-acylamidoderivaten von erythromycin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86672278A 1978-01-03 1978-01-03
US05/937,640 US4180654A (en) 1978-01-03 1978-08-29 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate

Publications (2)

Publication Number Publication Date
ATA2979A true ATA2979A (de) 1981-03-15
AT364457B AT364457B (de) 1981-10-27

Family

ID=27127966

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0002979A AT364457B (de) 1978-01-03 1979-01-02 Verfahren zur herstellung von neuen 4''-deoxy-4''-acylamidoderivaten von oleandomycin, erythromycin und erythromycincarbonat

Country Status (28)

Country Link
US (1) US4180654A (de)
JP (1) JPS5495585A (de)
AT (1) AT364457B (de)
AU (1) AU506684B2 (de)
CH (1) CH639972A5 (de)
CS (1) CS204042B2 (de)
DD (1) DD141026A5 (de)
DE (2) DE2953969C2 (de)
DK (1) DK147943C (de)
ES (2) ES476544A1 (de)
FI (1) FI68058C (de)
FR (1) FR2413403A1 (de)
GB (1) GB2013181B (de)
GR (1) GR72779B (de)
HU (1) HU180276B (de)
IE (1) IE47642B1 (de)
IL (1) IL56363A (de)
IN (1) IN150395B (de)
IT (1) IT1109925B (de)
LU (1) LU80747A1 (de)
NL (1) NL176461C (de)
NO (2) NO146711C (de)
NZ (1) NZ189274A (de)
PH (4) PH14745A (de)
PL (2) PL118573B1 (de)
PT (1) PT69014A (de)
SE (2) SE447118B (de)
YU (2) YU312278A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6211669Y2 (de) * 1980-10-06 1987-03-19
JPS5848285U (ja) * 1981-09-26 1983-04-01 コナミ工業株式会社 テ−ブル型テレビゲ−ム機
US4429116A (en) * 1982-12-27 1984-01-31 Pfizer Inc. Alkylated oleandomycin containing compounds
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
JPS62240086A (ja) * 1986-04-12 1987-10-20 株式会社 エ−ス電研 遊技機の前面構造
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
YU55690A (en) * 1990-03-21 1990-12-31 Pliva Pharm & Chem Works Process for preparing oleandomycin oxime
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310992D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
SI1628989T1 (sl) * 2003-05-13 2007-06-30 Glaxo Group Ltd Nove cikliäśne spojine s 14 in 15 obroäśnimi äśleni

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869445A (en) * 1973-05-03 1975-03-04 Abbott Lab 4{41 -O-sulfonyl erythromycin-9-O-oxime derivatives
US3884902A (en) * 1973-05-04 1975-05-20 Abbott Lab Sulfonyl derivatives of erythromycin
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US4063014A (en) * 1975-06-12 1977-12-13 Abbott Laboratories 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
IE44509B1 (en) * 1976-03-03 1981-12-30 Pfizer Semi-synthetic oleandomycins
US4069379A (en) * 1976-07-08 1978-01-17 Pfizer Inc. Semi-synthetic oleandomycins
US4090017A (en) * 1977-02-04 1978-05-16 Pfizer Inc. 4-Deoxy-4-substituted amino derivatives of oleandomycin
US4085119A (en) * 1977-02-04 1978-04-18 Pfizer Inc. 4-Substituted amino derivatives of oleandomycin

Also Published As

Publication number Publication date
JPS5734280B2 (de) 1982-07-22
PL117603B1 (en) 1981-08-31
NO820613L (no) 1979-07-04
PL212593A1 (pl) 1979-08-27
GB2013181A (en) 1979-08-08
IL56363A0 (en) 1979-03-12
FI68058B (fi) 1985-03-29
LU80747A1 (fr) 1979-09-07
IL56363A (en) 1982-12-31
YU312278A (en) 1983-01-21
DE2953969C2 (de) 1987-09-03
JPS5495585A (en) 1979-07-28
DE2900118C2 (de) 1987-09-17
NZ189274A (en) 1982-03-23
IT1109925B (it) 1985-12-23
YU213982A (en) 1983-02-28
DK147943B (da) 1985-01-14
SE8304417L (sv) 1983-08-15
AT364457B (de) 1981-10-27
SE7900028L (sv) 1979-07-04
IN150395B (de) 1982-09-25
ES476544A1 (es) 1979-12-01
FI790004A (fi) 1979-07-04
HU180276B (en) 1983-02-28
IT7919013A0 (it) 1979-01-02
AU4298578A (en) 1979-07-12
CH639972A5 (de) 1983-12-15
DE2900118A1 (de) 1979-07-05
DK147943C (da) 1985-08-05
NO147716B (no) 1983-02-21
DD141026A5 (de) 1980-04-09
NO147716C (no) 1983-06-01
PH15752A (en) 1983-03-18
US4180654A (en) 1979-12-25
PH15439A (en) 1983-01-18
PL118573B1 (en) 1981-10-31
PT69014A (en) 1979-02-01
CS204042B2 (en) 1981-03-31
GB2013181B (en) 1982-06-03
DK507778A (da) 1979-07-04
IE790005L (en) 1979-07-03
SE447118B (sv) 1986-10-27
NO790006L (no) 1979-07-04
PH14745A (en) 1981-11-20
GR72779B (de) 1983-12-05
NL7900006A (nl) 1979-07-05
ES482420A1 (es) 1980-09-01
NO146711B (no) 1982-08-16
NL176461C (nl) 1985-04-16
FR2413403B1 (de) 1982-07-23
IE47642B1 (en) 1984-05-16
FI68058C (fi) 1985-07-10
PH15626A (en) 1983-03-11
AU506684B2 (en) 1980-01-17
NO146711C (no) 1982-11-24
SE8304417D0 (sv) 1983-08-15
SE448385B (sv) 1987-02-16
FR2413403A1 (fr) 1979-07-27

Similar Documents

Publication Publication Date Title
AT373589B (de) Verfahren zur herstellung von neuen 5h-2,3benzodiazepin-derivaten und deren saeureadditions- salzen
AT363491B (de) Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen
AT374188B (de) Verfahren zur herstellung von neuen a-alkylimidazolderivaten und deren salzen
AT370408B (de) Verfahren zur herstellung von neuen phenylaethanolaminen und von salzen hiervon
ATA463779A (de) Verfahren zur herstellung von neuen phenylaethanolaminen und salzen hirvon
ATA2979A (de) Verfahren zur herstellung von neuen 4''-deoxy- -4''-acylamidoderivaten von oleandomycin, erythromycin und erythromycincarbonat
AT367432B (de) Verfahren zur herstellung von neuen 3",4"diacyltylosinderivaten
AT357274B (de) Verfahren zur herstellung von neuen derivaten des 20,21-dinoreburnamenins
AT365588B (de) Verfahren zur herstellung von neuen spiropyridochroman-4',5-hydantoinen
ATA93379A (de) Verfahren zur herstellung von neuen carbostyril- und oxindolderivaten
AT359474B (de) Verfahren zur herstellung von neuen 5-phenoxy- 6,7,8,9-tetrahydro-cyclohepten-7-aminen und von deren saeureadditionssalzen
AT369019B (de) Verfahren zur herstellung von neuen 5-niedrigalkal-2'-desoxyuridin-5'-monophosphaten
AT359070B (de) Verfahren zur herstellung von neuen 2,4-diamino -5-benzylpyrimidinen und deren salzen
AT346321B (de) Verfahren zur herstellung von neuen 4'- substituierten benzoylphenylnaphthalinen und den saeureadditionssalzen hievon
AT371439B (de) Verfahren zur herstellung von neuen n-substituierten moranolinderivaten und ihrer salze
ATA595880A (de) Verfahren zur herstellung von neuen 4''-deoxy-4''-acylamidoderivaten von erythromycin
AT367758B (de) Verfahren zur herstellung von neuen 20-methyl-13, 14-didehydro-pgi 2-derivaten
AT377258B (de) Verfahren zur herstellung von neuen 4-hydroxycumarin- und 1,3-indandion-derivaten
ATA296479A (de) Verfahren zur herstellung von neuen (1,2- dihydro-2-oxo-nicotinamido)-alkylbenzolsul- fonylharnstoffen und von deren salzen
AT354414B (de) Verfahren zur herstellung von neuen 3-(2',2', 2',1'-tetrahalogenaethyl)-cyclopropancarbon- saeuren und deren halogeniden
ATA770879A (de) Verfahren zur herstellung von neuen 4''- -erythromycin-a-derivaten
ATA770779A (de) Verfahren zur herstellung von neuen 4''- -erythromycin-a-derivaten
ATA42280A (de) Verfahren zur herstellung von neuen 2,4- -diamino-5-benzylpyrimidinen und deren salzen
ATA42180A (de) Verfahren zur herstellung von neuen 2,4- -diamino-5-benzylpyrimidinen und deren salzen
AT361936B (de) Verfahren zur herstellung von neuen 3,4- -dihydroxy-6-phenyl-4,5-dihydropyridazin und seiner tautomeren form

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee